Cargando…

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants

The incidence of migraine is higher among women than men and peaks during the reproductive years, when contraceptive medication use is common. Atogepant, a potent, selective antagonist of the calcitonin gene‒related peptide receptor—in development for migraine prevention—is thus likely to be used by...

Descripción completa

Detalles Bibliográficos
Autores principales: Ankrom, Wendy, Xu, Jialin, Vallee, Marie‐Helene, Dockendorf, Marissa F., Armas, Danielle, Boinpally, Ramesh, Min, K. Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496689/
https://www.ncbi.nlm.nih.gov/pubmed/32297990
http://dx.doi.org/10.1002/jcph.1610